logo-loader
OTCQB:MMEDF

MindMed Inc.

Receive alerts
Market:
OTCQB
Market Cap:
$75.1 m
Price
0.38 USD
Change
2.70%
52 weeks high
1.00
52 weeks low
0.08

In brief

Mind Medicine (MindMed) Inc. is a neuro-pharmaceutical company that discovers, develops and deploys psychedelic inspired medicines to improve health, promote wellness and alleviate suffering. The company's immediate priority is to address the opioid crisis by developing a non-hallucinogenic version of the psychedelic ibogaine. In addition, the company has established a microdosing division to conduct clinical trials of LSD microdosing for adult ADHD. The MindMed executive team brings extensive biopharmaceutical industry experience to this ground-breaking approach to the development of next-generation psychedelic medicines. 

Deep dive We explore the investor case for growth companies

Snapshot

The New York City-based company has several projects in various stages from planning to ongoing clinical trials with a strong focus on legendary LSD